A Randomized Phase III Trial Of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed By Weekly Paclitaxel With Or Without Carboplat
Posted Date: May 15, 2019
- Investigator: Elizabeth Shaughnessy
- Type of Study: Drug
The purpose of this study is to compare the good and bad effects of the chemotherapy drug, carboplatin, given with the usual chemotherapy drugs after surgery, compared to the usual chemotherapy drugs given without carboplatin. The addition of carboplatin to the usual chemotherapy could prevent your
Criteria:
To Be Eligible To Participate, Patients Must Have A Type Of Breast Cancer That Is Her2-Negative And
Keywords:
Triple Negative, Breast, Node Negative/Positi, Nrg-Br003, Cancer
For More Information:
Uc Cancer Center
513-584-7698
kastla@uc.edu